Raphas Co., Ltd. (KOSDAQ:214260)
12,830
+140 (1.10%)
At close: Jan 23, 2026
Raphas Revenue
Raphas had revenue of 9.60B KRW in the quarter ending September 30, 2025, with 52.84% growth. This brings the company's revenue in the last twelve months to 32.16B, up 13.31% year-over-year. In the year 2024, Raphas had annual revenue of 27.22B, down -2.58%.
Revenue (ttm)
32.16B
Revenue Growth
+13.31%
P/S Ratio
3.35
Revenue / Employee
407.14M
Employees
79
Market Cap
107.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 27.22B | -720.52M | -2.58% |
| Dec 31, 2023 | 27.94B | 4.30B | 18.18% |
| Dec 31, 2022 | 23.64B | 3.30B | 16.22% |
| Dec 31, 2021 | 20.34B | 2.48B | 13.87% |
| Dec 31, 2020 | 17.86B | -306.32M | -1.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CLIO Cosmetics Co.,Ltd | 326.53B |
| Englewood Lab | 204.62B |
| Manyo Factory | 118.72B |
| Newtree | 98.91B |
| Icure Pharmaceutical Incorporation | 93.22B |
| Genic | 85.47B |
| KODI CO., LTD | 79.37B |
| Coreana Cosmetics | 76.53B |